News mentioning $BMY
346 stories
Sep 9, 26CEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’
Sep 8, 26Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy
Sep 2, 26Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN deals